ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 99 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $915 | -32.4% | 1,242,370 | +15.7% | 0.00% | 0.0% |
| Q2 2023 | $1,353 | +99.3% | 1,074,070 | +14.7% | 0.00% | +100.0% |
| Q1 2023 | $679 | +52.2% | 936,070 | +10.8% | 0.00% | 0.0% |
| Q4 2022 | $446 | -100.0% | 844,770 | -22.9% | 0.00% | 0.0% |
| Q3 2022 | $913,000 | -57.9% | 1,095,710 | -44.9% | 0.00% | -66.7% |
| Q2 2022 | $2,169,000 | -17.4% | 1,989,995 | -5.3% | 0.00% | 0.0% |
| Q1 2022 | $2,626,000 | +40.2% | 2,100,492 | +79.5% | 0.00% | +50.0% |
| Q4 2021 | $1,873,000 | -73.1% | 1,170,340 | -64.6% | 0.00% | -77.8% |
| Q1 2021 | $6,972,000 | +1389.7% | 3,304,140 | +570.5% | 0.01% | +800.0% |
| Q4 2020 | $468,000 | +160.0% | 492,800 | +561.7% | 0.00% | – |
| Q3 2020 | $180,000 | +339.0% | 74,480 | +184.3% | 0.00% | – |
| Q4 2019 | $41,000 | – | 26,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 347,392 | $256 | 0.02% |
| XTX Topco Ltd | 167,427 | $123,310 | 0.02% |
| Laurion Capital Management LP | 2,225,800 | $1,639,302 | 0.01% |
| Virtu Financial LLC | 80,728 | $59 | 0.01% |
| Renaissance Technologies | 1,242,370 | $915 | 0.00% |
| LVM CAPITAL MANAGEMENT LTD/MI | 21,000 | $15 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 50,000 | $36,825 | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 133,591 | $98,390 | 0.00% |
| Caption Management, LLC | 75,000 | $55,238 | 0.00% |
| J. L. Bainbridge & Co., Inc. | 11,121 | $8,191 | 0.00% |